ACOTEC-B(06669): The registration application for the microcatheter V-otter has been approved by the China National Medical Products Administration.
Senruida Medical-B (06669) announced that on December 1, 2025, the Group received the registration approval from the China National Medical Products Administration for the microcatheter V-otter.
ACOTEC-B(06669) announced that on December 1, 2025, the group received approval from the China National Medical Products Administration for the registration of V-otter, a microcatheter. V-otter is used in peripheral and coronary artery percutaneous interventions to deliver diagnostic, occlusive, or therapeutic materials once reaching the intended blood vessel site. V-otter is a microcatheter used in transarterial chemoembolization (TACE) procedures, featuring a large lumen design to effectively prevent catheter blockage during surgery. The product offers three options for the distal tip shape - straight, 45 single curve, and multiple curves - allowing for easy adaptation to different angles of branching blood vessels based on clinical needs, enabling precise and stable access to the target vessel and preparing for subsequent procedures. The company will conduct marketing activities in China at the appropriate time.
Related Articles

ASCLETIS-B (01672) spent HK$15.9275 million on December 3 to repurchase 1.306 million shares.

China Aluminum International Engineering Corporation (601068.SH) awarded the contract for a 30.3 billion yuan aluminum electrolysis project.

Yantai Dongcheng Bio(002675.SZ) subsidiary, Lanna Cheng, has obtained the license for production of radioactive pharmaceuticals.
ASCLETIS-B (01672) spent HK$15.9275 million on December 3 to repurchase 1.306 million shares.

China Aluminum International Engineering Corporation (601068.SH) awarded the contract for a 30.3 billion yuan aluminum electrolysis project.

Yantai Dongcheng Bio(002675.SZ) subsidiary, Lanna Cheng, has obtained the license for production of radioactive pharmaceuticals.






